Effect of a moderately hypoenergetic Mediterranean diet and exercise program on body cell mass and cardiovascular risk factors in obese women

Eur J Clin Nutr. 2008 Jul;62(7):892-7. doi: 10.1038/sj.ejcn.1602800. Epub 2007 May 16.

Abstract

Objective: To assess the effects of a moderately hypoenergetic Mediterranean diet (MHMD) and exercise program on body cell mass (BCM) and cardiovascular disease risk factors in obese women.

Subjects/methods: Forty-seven obese women, 39.7+/-13.2 years of age, with a body mass index (BMI)=30.7+/-6.0 kg/m(2), completed the study. The following were measured at baseline, 2 and 4 months: BCM, BCM index (BCMI), body weight, BMI, fat-free mass (FFM), fat mass (FM), total body water (TBW), extracellular water (ECW) and intracellular water (ICW) using bioelectrical impedance analysis; fasting blood glucose (FBG), serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglyceride (TG) concentrations; systolic (SBP) and diastolic (DBP) blood pressure.

Results: Body weight, BMI, FM, TC and TG significantly decreased (P<0.001; P<0.002 (TG)) at 2 and 4 months. FFM, TBW, ECW, FBG and DBP significantly decreased at 2 months (P<0.05 (FFM); P<0.001). LDL-C significantly decreased (P<0.001), while HDL-C significantly increased (P<0.002) at 4 months. BCM, BCMI, ICW and SBP remained stable over time.

Conclusion: BCM was preserved and cardiovascular disease risk factors improved in obese women placed on a MHMD and exercise program for 4 months.

MeSH terms

  • Adult
  • Aged
  • Biomarkers / blood
  • Blood Pressure / physiology
  • Body Composition / physiology*
  • Body Mass Index
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / epidemiology*
  • Combined Modality Therapy
  • Diet, Mediterranean
  • Diet, Reducing*
  • Electric Impedance
  • Exercise / physiology*
  • Female
  • Humans
  • Lipid Metabolism / physiology
  • Lipids / blood
  • Longitudinal Studies
  • Middle Aged
  • Obesity / blood*
  • Obesity / therapy*
  • Risk Factors
  • Treatment Outcome
  • Weight Loss / physiology*

Substances

  • Biomarkers
  • Lipids